Skip to main content
TASLY PHARMACEUTICAL GROUP CO.,LTD. logo

TASLY PHARMACEUTICAL GROUP CO.,LTD. — Investor Relations & Filings

Ticker · 600535 ISIN · CNE000001C81 LEI · 300300JB9F71F58FIC88 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,889 across all filing types
Latest filing 2020-06-05 Notice of Dividend Amou…
Country CN China
Listing Shanghai Stock Exchange 600535

About TASLY PHARMACEUTICAL GROUP CO.,LTD.

http://www.tasly.com

Tasly Pharmaceutical Group Co., Ltd. specializes in the research, development, and production of modern Traditional Chinese Medicine (TCM), biological products, and chemical pharmaceuticals. The company is primarily known for its flagship cardiovascular treatment, Compound Danshen Dripping Pills, which represents a significant advancement in the modernization and standardization of herbal medicine. Its therapeutic portfolio covers cardiovascular, cerebrovascular, digestive, and metabolic diseases, as well as oncology. Tasly utilizes high-tech manufacturing processes and maintains a strong focus on R&D to bridge traditional therapies with modern clinical standards. The organization also explores digital health solutions and innovative drug delivery systems to enhance its comprehensive healthcare offerings.

Recent filings

Filing Released Lang Actions
2019年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is an announcement regarding the implementation of the 2019 annual dividend distribution by the company 天士力医药集团股份有限公司. It details the dividend per share, relevant dates for dividend distribution, tax treatment, and procedural information for shareholders. The document is relatively short (3024 characters) and focuses on dividend payment details rather than presenting a full financial report or annual report. It is not a full Annual Report (10-K) or Interim Report (IR), nor is it a Management Report or Earnings Release. It is specifically about the dividend amount and payment details, which fits the category of Notice of Dividend Amount (DIV).
2020-06-05 Chinese
关于举行“投资者网上集体接待日”的公告
Investor Presentation Classification · 90% confidence The document is an announcement about an upcoming 'Investor Online Reception Day' event scheduled for June 10, 2020, where company executives will interact with investors. It references the prior release of the 2019 Annual Report but does not contain the report itself or detailed financial data. The document is short (459 characters) and serves as a notice for an investor event rather than a financial report or detailed presentation. Therefore, it fits best as an Investor Presentation (IP) type, as it focuses on investor communication and interaction rather than a formal report or regulatory filing.
2020-06-03 Chinese
关于以集中竞价交易方式回购公司股票的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's stock repurchase plan. It details the board meeting approval, previous announcements, and the status of the share buyback as of May 31, 2020, stating no shares have been repurchased yet. The document is short (628 characters) and focuses on the update of the share repurchase activity, which fits the description of a Transaction in Own Shares (POS) filing. It is not a full financial report or earnings release, nor is it a regulatory announcement unrelated to share transactions. Therefore, the appropriate classification is POS.
2020-05-31 Chinese
2019年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a 2019 Annual General Meeting (AGM) resolution announcement for the company 天士力医药集团股份有限公司. It details the date and location of the AGM, attendance, voting results on various proposals including the 2019 annual report and financial statements, and legal witness statements confirming the validity of the meeting and resolutions. The content is focused on the announcement of the voting results and resolutions passed at the AGM rather than the full annual report or financial statements themselves. The document length is 3843 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2020-05-18 Chinese
2019年年度股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2019 Annual General Meeting (AGM) of TianShiLi Pharmaceutical Group Co., Ltd. It details the legality and validity of the AGM procedures, attendance, voting, and resolutions passed. It references the 2019 Annual General Meeting and the related resolutions but does not contain the actual AGM materials or presentations. Instead, it is a legal opinion on the AGM process and results. This type of document is best classified under Declaration of Voting Results & Voting Rights Announcements (DVA) because it confirms the legality and validity of the AGM voting and resolutions, which aligns with the category description for official results from shareholder votes at any general meeting.
2020-05-18 Chinese
关于筹划重大资产出售的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of a major asset sale by the company TianShiLi Pharmaceutical Group Co., Ltd. It references previous announcements and ongoing discussions related to the asset sale, including regulatory compliance and risk warnings. The document is relatively short (1002 characters) and serves as a progress update rather than a full financial report or detailed transaction filing. It does not contain financial statements or detailed merger documentation but is an update on a capital restructuring event. Therefore, it fits best under Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as major asset sales.
2020-05-15 Chinese

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.